Apogee Biotechnology (United States)
- Research works
- 23 ▲ 39% vs 2013–17
- Citations
- 931 40.3 per fractional work
- Top-10% rate
- 15.8% record average 16.5%
- Open access
- 63% world 28%
Not ranked overall: Apogee Biotechnology (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at Apogee Biotechnology (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Cancer, Apoptosis, Insulin Resistance, Sphingolipids, Sphingosine-1-Phosphate, Cancer Therapy, Inflammation and Macrophages.
- Venture Capital
- Cell Death
- Transcriptional Regulation
- Tumor Microenvironment
- Macrophages
- Cancer Therapy
- Sphingolipids
- Apoptosis
- Cancer
- Insulin Resistance
- Sphingosine-1-Phosphate
- Inflammation
- Immunity
- HIF-1
- Warburg Effect
- Start-Up Firms
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 16 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 16 words, with their numbers
- Cancer8▲ 26×10 topics
- Apoptosis8▲ 83×5 topics
- Insulin Resistance6▲ 57×2 topics
- Sphingolipids6▲ 1854×1 topic
- Sphingosine-1-Phosphate6▲ 1854×1 topic
- Cancer Therapy3▲ 22×7 topics
- Inflammation2▲ 4.5×12 topics
- Macrophages1▲ 33×3 topics
- Immunity1▲ 15×3 topics
- Tumor Microenvironment1▲ 14×2 topics
- HIF-11▲ 64×1 topic
- Transcriptional Regulation1▲ 18×3 topics
- Warburg Effect1▲ 64×1 topic
- Cell Death1▲ 22×3 topics
- Start-Up Firms1▲ 198×1 topic
- Venture Capital1▲ 176×1 topic
Which research topics does Apogee Biotechnology (United States) publish most on?
By volume in 2022–2025: Sphingolipid Metabolism and Signaling, Cancer, Hypoxia, and Metabolism, Autophagy in Disease and Therapy and Phagocytosis and Immune Regulation.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Sphingolipid Metabolism and Signaling Molecular Biology 2 works
- 2 Cancer, Hypoxia, and Metabolism Cancer Research 1 works
- 3 Autophagy in Disease and Therapy Epidemiology 1 works
- 4 Phagocytosis and Immune Regulation Immunology 1 works
- 5 Metabolomics and Mass Spectrometry Studies Molecular Biology 0 works
- 6 Cell death mechanisms and regulation Molecular Biology 0 works
- 7 Endoplasmic Reticulum Stress and Disease Cell Biology 0 works
- 8 Neuroblastoma Research and Treatments Neurology 0 works
- 9 Adipokines, Inflammation, and Metabolic Diseases Epidemiology 0 works
- 10 COVID-19 Clinical Research Studies Infectious Diseases 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Apogee Biotechnology (United States)'s research output changed?
Output in 2018–2022 was 39% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Hummelstown
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.